In Silico-Guided Sequence Modifications of K-Ras Epitopes Improve Immunological Outcome Against G12V and G13D Mutant KRAS Antigens

PeerJ - United States
doi 10.7717/peerj.5056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

PeerJ

Related search

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Akt1 Deletion Prevents Lung Tumorigenesis by Mutant K-Ras

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Comparative Analysis of Radiosensitizers for K-Ras Mutant Rectal Cancers

PLoS ONE
Multidisciplinary
2013English

Supplemental Information 1: Mutant K-Ras G12A Peptide Sequences.

English

Supplemental Information 3: Mutant K-Ras G12D Peptide Sequences.

English

Dynamics of Membrane-Bound G12V KRAS Investigated by Simulation and Single Molecule FRET in Native Nanodiscs

Biophysical Journal
Biophysics
2019English

Vav1 and Mutant K-Ras Synergize in the Early Development of Pancreatic Ductal Adenocarcinoma in Mice

Life Science Alliance
Plant ScienceEcologyGeneticsMolecular BiologyBiochemistryMutagenesisHealthToxicology
2020English

Metabolic and Immunological Modifications Present in Alzheimer’s Disease

2018English

Coxsackievirus Type B3 Is a Potent Oncolytic Virus Against KRAS-Mutant Lung Adenocarcinoma

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy